EC
CRVS icon

EntryPoint Capital’s Corvus Pharmaceuticals CRVS Stock Holding History

EntryPoint Capital’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-53,745
Closed -$171K – 654
2025
Q1 		$171K Sell
53,745
-62,900
-54% -$200K 0.08% 568
2024
Q4 		$624K Buy
+116,645
New +$624K 0.26% 48